Trial Profile
Antiretroviral Therapy for Acute and Chronic HIV Infection
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Jul 2023
Price :
$35
*
At a glance
- Drugs Dolutegravir (Primary) ; Efavirenz (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Maraviroc; Raltegravir
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms AAHIV
- 21 Jun 2023 Planned number of patients changed from 644 to 722.
- 29 Jun 2020 Planned number of patients changed from 621 to 644.
- 19 Sep 2019 Planned number of patients changed from 549 to 621.